In contrast to ONECUT1, ONECUT2 expression has been shown to be elevated in multiple different cancers, including prostate cancer[6], ovarian cancer[9], gastric cancer[10], colorectal cancer[11], hepatocellular carcinoma[12], lung adenocarcinoma[13], and neuroendocrine tumors[6]. This evidence concerns the gene ONECUT2 and prostate carcinoma.